Suchen Sie nach Informationen zu Avexis-Hauptsitz? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.


AveXis, Inc. | LinkedIn

    https://de.linkedin.com/company/avexis-inc-
    AveXis, Inc. | 31.989 Follower:innen auf LinkedIn Transforming rare diseases through gene therapy | AveXis, a Novartis company, is the world’s leading gene therapy company, redefining the possibilities for patients and families affected by life-threatening genetic diseases through our innovative gene therapy platform. Founded in 2013 and headquartered in Bannockburn, IL, the …

AveXis, Inc. Email Formats & Employee Phones — Biotech

    https://www.signalhire.com/companies/avexis-inc
    Contact and general information about AveXis, Inc. company, headquarter location in Bannockburn, Illinois. Email formats & phone numbers of …

Avexis

    https://www.avexis.eu/home
    Search this site. Skip to main content. Skip to navigation

AveXis Inc - Company Profile and News - Bloomberg …

    https://www.bloomberg.com/profile/company/AVXS:US
    AveXis Inc. AveXis, Inc. operates as a clinical-stage gene therapy company. The Company focuses on developing and commercializing novel treatments for patients suffering from rare and life ...

SEC.gov | AveXis, Inc.

    https://www.sec.gov/avexis-inc
    AveXis, Inc. Oct. 2, 2017 Downloads. pdf 17-04102-T.pdf (430.33 KB) Modified: Oct. 2, 2017 STAY CONNECTED 1 Twitter 2 Facebook 3 RSS 4 YouTube 6 LinkedIn 8 Email Updates. About The SEC. Budget & Performance; Careers; Commission Votes; Contact; Contracts; Data Resources; ...

AVEXIS INC - MarketScreener.com

    https://www.marketscreener.com/quote/stock/AVEXIS-INC-26304175/company/
    AVEXIS INC : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: | Nasdaq

AveXis renamed Novartis Gene Therapies, signifying the …

    https://www.novartis.com/news/avexis-renamed-novartis-gene-therapies-signifying-growing-importance-gene-therapy-novartis-corporate-strategy
    Since its acquisition in May 2018, AveXis has been a high-profile and extremely successful investment for Novartis, evolving from a clinical-stage to a commercial organization. The most widely used gene therapy in the world, Zolgensma treats spinal muscular atrophy (SMA), the leading genetic cause of infant death.

Novartis Gene Therapies Company Profile - Craft

    https://craft.co/avexis-
    Novartis Gene Therapies (formerly known as AveXis) is a biotech company developing innovative treatments for rare and life-threatening genetic diseases. It offers AVXS-101, a gene therapy product candidate for the treatment of spinal muscular atrophy Type 1. The company partners with academics, biotechnology, pharmaceutical companies, and ...

Working at AveXis: Employee Reviews | Indeed.com

    https://www.indeed.com/cmp/Avexis/reviews
    Manager (Former Employee) - San Diego, CA - July 27, 2021. I really enjoyed working here when it was Avexis and before the Novartis take over. Was always fast paced and ambitious timelines, but you felt supported by everyone and we were super busy doing great work. Pros. Great leadership, company culture, and comp. Cons.

AveXis Inc. HR Department | AveXis Inc. Human Resources

    https://rocketreach.co/avexis-inc-hr-department_b5f7f3a4f42d2a91
    IT Department. AveXis Inc. employs 220 employees. The AveXis Inc. management team includes Omar Dabbous (Vice President, Global Health Economics and Outcomes Research and Real World Evidence), Satish Tripathi (Vice President, Global Regulatory Affairs, Clinical Quality Assurance and Pharmacology - Toxicology), and Heather Connelly (Vice ...

Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Avexis-Hauptsitz gefunden haben.